Clinical Trial

Intermittent Fasting and Mediterranean Diet in Patient With Multiple Sclerosis

Recruiting
View on ClinicalTrials.gov →
Summary
When the literature was reviewed, there is no study in which the effects of intermittent fasting and Mediterranean diet on quality of life, sleep, circadian rhythm and appetite hormones leptin and ghrelin levels in MS patients were evaluated and the two diet types were comparatively examined in terms of all these parameters.
Trial Details
NCT Number NCT06546033
Lead Sponsor Nigde Omer Halisdemir University
Collaborators: Acibadem University
Conditions Multiple Sclerosis, Intermittent Fasting
Enrollment 34 participants
Start Date 2024-05-02
Primary Completion 2026-09-02 (estimated)
Study Completion 2026-12-02 (estimated)
Updated on ClinicalTrials.gov 2024-08-09